AN ASSOCIATION STUDY OF HLA WITH THE KINETICS OF SARS-COV-2 SPIKE SPECIFIC IGG ANTIBODY RESPONSES TO BNT162B2 MRNA VACCINE

被引：0

作者：

Khor, S. ^{[1
]}

Omae, Y. ^{[1
]}

Tokunaga, K. ^{[1
]}

Takeuchi, J. ^{[2
]}

Kimura, M. ^{[2
]}

Fukunaga, A. ^{[3
]}

Yamamoto, S. ^{[3
]}

Mizoue, T. ^{[3
]}

Tanaka, A. ^{[4
]}

Matsuda, K. ^{[5
]}

Maeda, K. ^{[5
]}

Mitsuya, H. ^{[5
]}

Ueda, G. ^{[6
]}

Ujiie, M. ^{[7
]}

Omagari, N. ^{[7
]}

Sugiura, W. ^{[8
]}

机构：

[1] Natl Ctr Global Hlth & Med, Genome Med Sci Project, Tokyo, Japan

[2] Natl Ctr Global Hlth & Med, Dept Acad Ind Partnerships Promot, Ctr Clin Sci, Tokyo, Japan

[3] Natl Ctr Global Hlth & Med, Dept Epidemiol & Prevent, Ctr Clin Sci, Tokyo, Japan

[4] Natl Ctr Global Hlth & Med, Ctr Hosp, Dept Lab Testing, Tokyo, Japan

[5] Natl Ctr Global Hlth & Med, Dept Refractory Viral Infect, Res Inst, Tokyo, Japan

[6] Abbott Japan LLC, Div Core Diagnost, Tokyo, Japan

[7] Natl Ctr Global Hlth & Med, Dis Control & Prevent Ctr, Tokyo, Japan

[8] Natl Ctr Global Hlth & Med, Ctr Clin Sci, Tokyo, Japan

来源：

HUMAN IMMUNOLOGY | 2022年 / 83卷

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

P77

引用

页码：121 / 121

页数：1

共 50 条

[31] Large-Scale Study of Antibody Titer Decay following BNT162b2 mRNA Vaccine or SARS-CoV-2 Infection
Israel, Ariel
Shenhar, Yotam
Green, Ilan
Merzon, Eugene
Golan-Cohen, Avivit
Schaeffer, Alejandro A.
Ruppin, Eytan
Vinker, Shlomo
Magen, Eli
VACCINES, 2022, 10 (01)
[32] Kinetics of SARS-CoV-2 anti-S IgG after BNT162b2 vaccination
Grupel, Daniel
Gazit, Sivan
Schreiber, Licita
Nadler, Varda
Wolf, Tamar
Lazar, Rachel
Supino-Rosin, Lia
Perez, Galit
Peretz, Asaf
Ben Tov, Amir
Mizrahi-Reuveni, Miri
Chodick, Gabriel
Patalon, Tal
VACCINE, 2020, 39 (38) : 5337 - 5340
[33] Humoral and cellular response to SARS-CoV-2 BNT162b2 mRNA vaccine in hemodialysis patients
Melin, Jan
Svensson, Maria K.
Albinsson, Bo
Winqvist, Ola
Pauksens, Karlis
BMC IMMUNOLOGY, 2021, 22 (01)
[34] Humoral and cellular response to SARS-CoV-2 BNT162b2 mRNA vaccine in hemodialysis patients
Jan Melin
Maria K. Svensson
Bo Albinsson
Ola Winqvist
Karlis Pauksens
BMC Immunology, 22
[35] Central diabetes insipidus: a late sequela of BNT162b2 SARS-CoV-2 mRNA vaccine?
Ishay, Avraham
Shacham, Elena Chertok
BMC ENDOCRINE DISORDERS, 2023, 23 (01)
[36] Central diabetes insipidus: a late sequela of BNT162b2 SARS-CoV-2 mRNA vaccine?
Avraham Ishay
Elena Chertok Shacham
BMC Endocrine Disorders, 23
[37] Antibody levels after BNT162b2 vaccine booster and SARS-CoV-2 Omicron infection
Vietri, Maria Teresa
D'Elia, Giovanna
Caliendo, Gemma
Passariello, Luana
Albanese, Luisa
Molinari, Anna Maria
Angelillo, Italo Francesco
VACCINE, 2022, 40 (39) : 5726 - 5731
[38] Evaluation of the SARS-CoV-2 Antibody Response to the BNT162b2 Vaccine in Patients Undergoing Hemodialysis
Yau, Kevin
Abe, Kento T.
Naimark, David
Oliver, Matthew J.
Perl, Jeffrey
Leis, Jerome A.
Bolotin, Shelly
Tran, Vanessa
Mullin, Sarah, I
Shadowitz, Ellen
Gonzalez, Anny
Sukovic, Tatjana
Garnham-Takaoka, Julie
de Launay, Keelia Quinn
Takaoka, Alyson
Straus, Sharon E.
McGeer, Allison J.
Chan, Christopher T.
Colwill, Karen
Gingras, Anne-Claude
Hladunewich, Michelle A.
JAMA NETWORK OPEN, 2021, 4 (09)
[39] Antibody response in individuals infected with SARS-CoV-2 early after the first dose of the BNT162b2 mRNA vaccine
Gobbi, Federico
Buonfrate, Dora
Silva, Ronaldo
Martini, Davide
Bisoffi, Zeno
Piubelli, Chiara
Riccetti, Silvia
Sinigaglia, Alessandro
Barzon, Luisa
JOURNAL OF INFECTION, 2022, 84 (01) : 94 - 118
[40] Antibody Response to the BNT162b2 mRNA COVID-19 Vaccine in Subjects with Prior SARS-CoV-2 Infection
Gobbi, Federico
Buonfrate, Dora
Moro, Lucia
Rodari, Paola
Piubelli, Chiara
Caldrer, Sara
Riccetti, Silvia
Sinigaglia, Alessandro
Barzon, Luisa
VIRUSES-BASEL, 2021, 13 (03):

← 1 2 3 4 5 →